6505--ILLUCCIX PSMA VASD
ID: 36C26225Q0343Type: Special Notice
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF262-NETWORK CONTRACT OFFICE 22 (36C262)Gilbert, AZ, 85297, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/f7f2981e1dcd425d9379db55ab36d26e/view
Timeline
    Description

    The Department of Veterans Affairs (VA), through the Network Contracting Office (NCO) 22, intends to award a sole source firm-fixed price contract to Cardinal Health 414, LLC for the procurement of Illuccix PSMA radioactive therapy injections. This procurement is justified under FAR 8.405-6(a)(1)(B), as only one source can provide the unique supplies necessary for treating prostate cancer patients undergoing Positron Emission Tomography (PET) imaging. The Illuccix PSMA injection is FDA approved for patients with prostate cancer, particularly for those whose cancer may have metastasized or recurred, making it a critical component in their treatment. Interested parties must submit a tailored capability statement and relevant company information by 10:00 AM PT on January 21, 2025, to Hestia.Sim@va.gov, as the VA reserves the right to proceed with Cardinal Health if no adequate responses are received.

    Point(s) of Contact
    Hestia SimContract Specialist
    Hestia.Sim@va.gov
    Files
    Title
    Posted
    36C26225Q0343.docx
    The Department of Veterans Affairs (VA), specifically the Network Contracting Office (NCO) 22, intends to award a sole source firm-fixed price contract to Cardinal Health 414, LLC for the procurement of Illuccix PSMA radioactive therapy injections. This contract is justified under FAR 8.405-6(a)(1)(B), indicating that only one source can provide the unique supplies required for treating prostate cancer patients undergoing PET imaging. Interested parties must demonstrate their capability to provide the radiopharmaceuticals, ensuring they are FDA certified and comply with Nuclear Regulatory Commission regulations. Responses to this notice are due by January 21, 2025, and must include specific company information, including a tailored capability statement. The VA will evaluate submissions but reserves the right to proceed with the procurement directly with Cardinal Health if no adequate responses are received. This notice is part of the federal acquisition process to ensure transparency and competition, even though this particular procurement is not open to competitive bids.
    Lifecycle
    Title
    Type
    6505--ILLUCCIX PSMA VASD
    Currently viewing
    Special Notice
    Similar Opportunities
    6515--NOTICE OF INTENT ACIST CONTRAST DYE INJECTOR SYSTEM AT THE JESSE BROWN VA MEDICAL CENTER IN CHICAGO, IL 60614
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to procure an ACIST CVi Standard Contrast Dye Injector System for the Jesse Brown VA Medical Center in Chicago, IL. This sole source contract will be awarded to B2H Consulting Group LLC, the exclusive authorized distributor of ACIST products, to replace an end-of-life system that is critical for performing coronary angiograms, a procedure unsupported by other available contrast injectors. The ACIST injector's unique microcatheter technology is particularly advantageous for chronic total occlusion cases, ensuring compliance with infection control standards in clinical settings. Interested parties must submit written evidence of their capability to meet these requirements to Contract Specialist John Roskowski at peter.roskowski@va.gov by 10:00 AM (Central) on January 16, 2024.
    6505--Intent to Sole Source Central Admixture Pharmacy Services (CAPS) James A. Haley Veterans' Hospital
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to negotiate a sole source contract with Central Admixture Pharmacy Services (CAPS) for the full-service maintenance of a proprietary Total Parenteral Nutrition system at the James A. Haley Veterans' Hospital in Tampa, Florida. This procurement is justified under FAR 6.302-1, as CAPS is the only responsible source capable of meeting the unique requirements due to their exclusive knowledge of the system's design and the critical nature of patient care training associated with it. Interested parties that believe they can fulfill the specified capabilities are invited to submit their information by 11:00 AM EST on January 21, 2025; however, this notice does not constitute a request for quotations, and the government will proceed with CAPS if no other responses are received. For inquiries, interested parties may contact Contract Specialist Katrina Tavares at katrina.tavares@va.gov or by phone at 813-729-3586.
    6515--QDOT micro catheter
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 6, intends to conduct a sole source procurement for the QDOT micro catheter, targeting J&J MedTech as the exclusive supplier. This procurement is critical for providing new Original Equipment Manufacturer (OEM) medical supplies, ensuring compliance with warranty and service requirements, and rejecting any gray market or remanufactured items. The contract period is set from January 31, 2025, to March 31, 2025, with interested parties required to express their capabilities via email by January 16, 2025, as telephone inquiries will not be accepted. For further inquiries, contact Contract Specialist Serina Black at serina.black1@va.gov or call 757-315-3965.
    6505--Tamsulosin Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0011 concerning the procurement of Tamsulosin Hydrochloride (HCL) Capsules. This procurement aims to ensure an uninterrupted supply of Tamsulosin HCL for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare facilities, with one contract awarded to a responsible offeror capable of meeting these needs over a base period of one year, plus four optional one-year extensions. The estimated annual requirements include approximately 1.4 million bottles of 90-count Tamsulosin HCL 0.4mg capsules, along with options for larger packaging sizes, highlighting the importance of consistent medicinal supply for veteran healthcare. Interested vendors should note that the solicitation will be released electronically on or about January 7, 2025, with responses due by January 21, 2025; inquiries can be directed to Contract Specialist Andrew Cazares at Andrew.Cazares@va.gov or (708) 786-4990.
    J065--** Intent to Sole Source** UVE Annual Service
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a sole source contract to Claflin Service Company for the provision of UVE annual service and access to the UVE protocol management platform, which is essential for the operations of the Chalmers P. Wylie VA Ambulatory Care Center. This contract will cover the period from February 18, 2025, to February 17, 2026, with the possibility of three additional one-year extensions. The services sought are critical for maintaining the functionality and reliability of medical equipment, ensuring high-quality support for healthcare operations. Interested vendors must submit their capability statements, including detailed company information and relevant experience, by January 16, 2025, to Margaret Swetel at Margaret.Swetel@va.gov, as the procurement falls under NAICS code 811210, which pertains to electronic and precision equipment repair and maintenance.
    Nuclear Pharmaceuticals
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is soliciting proposals for the procurement of nuclear medicine pharmaceuticals and related products for the Dwight D. Eisenhower Army Medical Center's Radiology Department. The contract aims to secure FDA-approved radiopharmaceuticals, including Technelite Generators, Cardiolite Packs, and Pylarify doses, with a focus on timely delivery and compliance with federal regulations, particularly promoting opportunities for women-owned small businesses. This procurement is critical for maintaining operational effectiveness in military healthcare, ensuring that essential medical supplies are available for patient care. Interested vendors should contact Jacquetta White at jacquetta.o.white.civ@health.mil or Sebrena L. Lane at sebrena.l.hackleylane.civ@health.mil for further details, with the contract covering multiple delivery periods from 2025 to 2028.
    6515--Lumenis Stellar IPL w/Qswitch
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 8, intends to award a sole-source, firm-fixed contract to Melling Medical for the procurement of the Lumenis Stellar IPL with Q-switch, including ReSurFX and YAG systems, for the Dermatology Department at James A. Haley Veterans Hospital in Tampa, Florida. This procurement is essential for providing specialized dermatological services and is compliant with FAR regulations that allow for sole-source contracts when only one source can meet the required quality standards. The contract is set to run from January 20, 2024, to February 19, 2024, and interested parties are invited to submit capabilities statements by 10:00 AM EST on January 17, 2025, to Contracting Officer Marcus Lewis at Marcus.Lewis2@va.gov, as no competitive proposals will be solicited.
    6515--Intent to Sole Source Da Vinci Instrument Trays
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through Network Contracting Office 8 (NCO 8), intends to make a sole source award to Summit Medical LLC for the procurement of seventy-six sterilization instrument trays. These trays are critical for the C.W. Bill Young VA Medical Center’s Sterile Processing Service, facilitating the storage and reprocessing of da Vinci Robotic instruments. The procurement is justified under FAR 13.106-1(b)(1) due to the lack of alternative suppliers that can meet the agency's specific requirements, with an anticipated period of performance of 60 days after the award. Interested parties may submit capability statements by 12:00 PM EST on January 17, 2025, via email to Lakiesha Anderson at Lakiesha.Anderson@va.gov, noting that no reimbursement will be provided for preparation costs.
    Mimics 3D Software
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to solicit and negotiate a sole-source contract for the procurement of Mimics 3D Software from Materialise USA LLC. This procurement aims to replace the existing yearly site license with a more comprehensive five-year license that will facilitate the use of the software across multiple VA locations, enhancing the VA San Francisco Health Care System's capabilities in 3D modeling for clinical applications. The contract will include provisions for installation, maintenance, and compliance with FDA regulations, ensuring the software integrates seamlessly with existing hardware while adhering to VA security standards. Interested parties must submit their statements of capability and relevant information to Shanel Pagaragan at Shanel.Pagaragan@va.gov by January 17, 2025, at 10:00 AM Hawaii Standard Time.
    W065--Airgas Cylinder Lease Rentals
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to enter into a sole-source contract with Airgas USA, LLC for the lease of medical gas cylinders at the Providence VA Medical Center. The procurement encompasses a base period of one year, with the option to extend for an additional four years, and includes responsibilities such as the leasing, delivery, removal, and maintenance of medical gas cylinders, all of which must meet FDA standards. These services are critical for ensuring the availability of medical gases necessary for patient care, highlighting the specialized nature of the requirements. Interested parties may submit capability statements by January 17, 2025, to Rosangela Pereira at Rosangela.Pereira@va.gov, as the VA seeks to determine if competitive procedures could be utilized for this acquisition.